Bryce Harrison
Medicinal Chemist/Senior Director at Morphic Therapeutic
- Role
- Senior Director at Morphic Therapeutic
- Location
- Boston, MA, US
- LinkedIn followers
- 500 followers
About Bryce Harrison
Medicinal chemist with 15 years of drug discovery experience with a proven record of generating creative ideas, effectively working in cross-disciplinary teams, supervising reports and directing external collaborators. • Key contributor to teams that delivered three clinical compounds and three development candidates • Medicinal chemistry leader experienced in hit-to-lead, lead optimization and candidate selection • Skilled synthetic organic chemist with excellent laboratory technique Co-inventor of Sotagliflozin (LX4211), first-in-class dual SGLT1/2 inhibitor, phase 3 clinical trials for diabetes. Co-inventor of LX2761, locally acting SGLT1 inhibitor, clinical candidate for diabetes. Chemistry lead for the discovery of LX7101, LIM-kinase inhibitor, completed phase 1 clinical trials for glaucoma. Co-inventor of two additional preclinical candidates still under investigation.
Experience
Senior Director
Jan 2023 — Present · Waltham, MA, US
Education
Brigham Young University
BS, Chemistry
1992 — 1998
Harvard University
PhD, Organic Chemistry
1998 — 2003
Find verified contacts for anyone on LinkedIn
Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.
Free plan included · No credit card required
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.